Subunit composition of AMPK trimers present in the cytokinetic apparatus: Implications for drug target identification

Cell Cycle

Volumn 11, Issue 5, 2012, Pages 917-921

  Pinter, Katalin ^a   Jefferson, Andrew ^a   Czibik, Gabor ^a   Watkins, Hugh ^a   Redwood, Charles ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AMP activated protein kinase; Cytokinesis; Isoforms; Phosphorylation; Subcellular localization

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA 2; UNCLASSIFIED DRUG;

ARTICLE; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL KINETICS; CYTOSKELETON; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 84857926956     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.5.19412     Document Type: Article

References (34)

1. Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007; 47:185-210; PMID:16879084; http://dx.doi.org/10.1146/ annurev.pharmtox.47.120505.105304.
2. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, et al. AMPKbeta subunit targets metabolic stress sensing to glycogen. Curr Biol 2003; 13:867-71; PMID:12747837; http://dx.doi. org/10.1016/S0960-9822(03)00292- 6.
3. Birk JB, Wojtaszewski JF. Predominant alpha2/ beta2/gamma3 AMPK activation during exercise in human skeletal muscle. J Physiol 2006; 577:1021-32; PMID:17038425; http://dx.doi.org/10.1113/jphysiol. 2006.120972.
4. McGee SL, Howlett KF, Starkie RL, Cameron-Smith D, Kemp BE, Hargreaves M. Exercise increases nuclear AMPKalpha2 in human skeletal muscle. Diabetes 2003; 52:926-8; PMID:12663462; http://dx.doi. org/10.2337/diabetes.52.4.926.
5. Treebak JT, Birk JB, Hansen BF, Olsen GS, Wojtaszewski JF. A-769662 activates AMPK beta1- containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am J Physiol Cell Physiol 2009; 297:1041-52; PMID:19657063; http://dx.doi. org/10.1152/ajpcell.00051. 2009.
6. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, et al. AMP-activated protein kinase: greater AMP dependence and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 1998; 334:177-87; PMID:9693118.
7. Gregor M, Zeöld A, Oehler S, Marobela KA, Fuchs P, Weigel G, et al. Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres. J Cell Sci 2006; 119:1864-75; PMID:16608880; http://dx.doi.org/10.1242/ jcs.02891.
8. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 2000; 346:659-69; PMID:10698692; http://dx.doi.org/10.1042/ 0264-6021:3460659.
9. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 2004; 113:274-84; PMID:14722619.
10. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001; 10:1215-20; PMID:11371514; http://dx.doi.org/10.1093/hmg/10.11.1215.
11. Oakhill JS, Scott JW, Kemp BE. Structure and function of AMP-activated protein kinase. Acta Physiol (Oxf) 2009; 196:3-14; PMID:19245650; http://dx.doi. org/10.1111/j.1748-16.2009.01977.x.
12. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 2007; 447:1017-20; PMID:17486097; http://dx.doi. org/10.1038/nature05828.
13. Ma X, Jana SS, Conti MA, Kawamoto S, Claycomb WC, Adelstein RS. Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis. Mol Biol Cell 2010; 21:3952-62; PMID:20861308; http://dx.doi. org/10.1091/mbc.E10-04-0293.
14. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle 2009; 8:2385-98; PMID:19556893; http:// dx.doi.org/10.4161/cc.8.15.9082.
15. Thr172) in human cancer cells. Cell Cycle 2009; 8:788-91; PMID:19221486; http:// dx.doi.org/10.4161/cc.8.5.7787.
16. Vazquez-Martin A, Oliveras-Ferraros C, Lopez-Bonet E, Menendez JA. AMPK: Evidence for an energy- sensing cytokinetic tumor suppressor. Cell Cycle 2009; 8:3679-83; PMID:19844168; http://dx.doi. org/10.4161/cc.8.22.9905.
17. Downs SM, Ya R, Davis CC. Role of AMPK throughout meiotic maturation in the mouse oocyte: evidence for promotion of polar body formation and suppression of premature activation. Mol Reprod Dev 2010; 77:888-99; PMID:20830737; http://dx.doi. org/10.1002/mrd.21229.
18. Nakano A, Kato H, Watanabe T, Min KD, Yamazaki S, Asano Y, et al. AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol 2010; 12:583-90; PMID:20495555; http://dx.doi. org/10.1038/ncb2060.
19. Bungard D, Fuerth BJ, Zeng PY, Faubert B, Maas NL, Viollet B, et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 2010; 329:1201-5; PMID:20647423; http://dx.doi.org/10. 1126/science.1191241.
20. Ramsby ML, Makowski GS, Khairallah EA. Differential detergent fractionation of isolated hepatocytes: biochemical, immunochemical and two-dimensional gel electrophoresis characterization of cytoskeletal and noncytoskeletal compartments. Electrophoresis 1994; 15:265-77; PMID:8026443; http://dx.doi. org/10.1002/elps.1150150146.
21. Colombo SL, Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 2009; 421:163-9; PMID:19442239; http://dx.doi. org/10.1042/BJ20090613.
22. Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 2007; 27:4317-27; PMID:17420279; http://dx.doi. org/10.1128/MCB.02222-06.
23. Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, et al. Chemical Genetic Screen for AMPKα2 Substrates Uncovers a Network of Proteins Involved in Mitosis. Mol Cell 2011; 44:878-92; PMID:22137581; http://dx.doi.org/10.1016/j.molcel.2011.11.005.
24. Namiki T, Coelho SG, Hearing VJ. NUAK2: an emerging acral melanoma oncogene. Oncotarget 2011; 2:695-704; PMID:21911917.
25. Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Menendez JA. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus. Cell Cycle 2011; 10:1295-302; PMID:21474997; http://dx.doi.org/10.4161/ cc.10.8.15342.
26. Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys 2010; 78:221-9; PMID:20615625; http://dx.doi. org/10.1016/j.ijrobp.2010.03.005.
27. Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, et al. Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. J Cell Biol 2011; 194:209-27; PMID:21768291; http://dx.doi.org/10.1083/jcb.201105010.
28. Kazgan N, Williams T, Forsberg LJ, Brenman JE. Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell 2010; 21:3433-42; PMID:20685962; http://dx.doi. org/10.1091/mbc.E10-04-0347.
29. Townley R, Shapiro L. Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science 2007; 315:1726-9; PMID:17289942; http://dx.doi.org/10.1126/science.1137503.
30. Wojtaszewski JF, Birk JB, Frøsig C, Holten M, Pilegaard H, Dela F. 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 2005; 564:563-73; PMID:15718261; http://dx.doi.org/10.1113/ jphysiol.2005.082669.
31. Foretz M, Hébrard S, Guihard S, Leclerc J, Do Cruzeiro M, Hamard G, et al. The AMPKγ1 subunit plays an essential role in erythrocyte membrane elasticity, and its genetic inactivation induces splenomegaly and anemia. FASEB J 2011; 25:337-47; PMID:20881209; http:// dx.doi.org/10.1096/fj. 10-169383.
32. Bogachus LD, Turcotte LP. Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol 2010; 299:1549-61; PMID:20844250; http://dx.doi. org/10.1152/ajpcell.00279.2010.
33. Scott JW, van Denderen BJ, Jorgensen SB, Honeyman JE, Steinberg GR, Oakhill JS, et al. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol 2008; 15:1220-30; PMID:19022182; http://dx.doi. org/10.1016/j.chembiol.2008.10.005.
34. Chiacchiera F, Simone C. The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 2010; 9:1091-6; PMID:20190568; http://dx.doi.org/10.4161/ cc.9.6.11035.